Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Podgor

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1990
The incidence of retinoblastoma in the United States: 1974 through 1985A Tamboli, M J Podgor, J W Horm
Biometrics|April 21, 2001
Efficiency robust tests for survival or ordered categorical dataB Freidlin, M J Podgor, J L Gastwirth
American Journal of Epidemiology|March 1, 1992
Acceptable values of kappa for comparison of two groupsD G Seigel, M J Podgor, N A Remaley
Statistics in Medicine|October 15, 1996
Efficiency robust tests of independence in contingency tables with ordered classificationsM J Podgor, J L Gastwirth, C R Mehta
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 1, 1986
Color vision defects in early diabetic retinopathyM S Roy, R D Gunkel, M J Podgor
Ophthalmology|July 1, 1987
Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12F L Ferris, M J Podgor, M D Davis
The New England Journal of Medicine|October 13, 1994
Mortality in sickle cell diseaseG P Rodgers, E C Walker, M J Podgor
The American Journal of the Medical Sciences|March 1, 1993
Is "relative" hypertension a risk factor for vaso-occlusive complications in sickle cell disease?G P Rodgers, E C Walker, M J Podgor
Investigative Ophthalmology & Visual Science|June 1, 1988
Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathyM S Roy, M J Podgor, M E Rick
The New England Journal of Medicine|December 5, 1985
Lens changes and survival in a population-based studyM J Podgor, G H Cassel, W B Kannel
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1990
The incidence of retinoblastoma in the United States: 1974 through 1985A Tamboli, M J Podgor, J W Horm
Biometrics|April 21, 2001
Efficiency robust tests for survival or ordered categorical dataB Freidlin, M J Podgor, J L Gastwirth
American Journal of Epidemiology|March 1, 1992
Acceptable values of kappa for comparison of two groupsD G Seigel, M J Podgor, N A Remaley
Statistics in Medicine|October 15, 1996
Efficiency robust tests of independence in contingency tables with ordered classificationsM J Podgor, J L Gastwirth, C R Mehta
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 1, 1986
Color vision defects in early diabetic retinopathyM S Roy, R D Gunkel, M J Podgor
Ophthalmology|July 1, 1987
Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12F L Ferris, M J Podgor, M D Davis
The New England Journal of Medicine|October 13, 1994
Mortality in sickle cell diseaseG P Rodgers, E C Walker, M J Podgor
The American Journal of the Medical Sciences|March 1, 1993
Is "relative" hypertension a risk factor for vaso-occlusive complications in sickle cell disease?G P Rodgers, E C Walker, M J Podgor
Investigative Ophthalmology & Visual Science|June 1, 1988
Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathyM S Roy, M J Podgor, M E Rick
The New England Journal of Medicine|December 5, 1985
Lens changes and survival in a population-based studyM J Podgor, G H Cassel, W B Kannel
Pageof 5